Dow Down 0.92% Nasdaq Down 0.83%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM
3.31 Up 0.07(2.16%) Oct 22, 3:59PM EDT
Prev Close:3.24
Open:3.24
Bid:3.17 x 1000
Ask:N/A
1y Target Est:9.67
Beta:1.34
Next Earnings Date:N/A
Day's Range:3.15 - 3.36
52wk Range:2.68 - 5.25
Volume:141,485
Avg Vol (3m):86,934
Market Cap:75.06M
P/E (ttm):N/A
EPS (ttm):-0.97
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYCC

Comparison

Symbol% ChgMkt Cap
CYCCUp 2.16%75.06M
AZNDown 0.32%86.87B
JNJUp 0.86%285.47B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):54.02
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.01
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback